EX-12 7 y54537ex12.txt COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES EXHIBIT 12 REGENERON PHARMACEUTICALS, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
NINE MONTHS YEARS ENDED DECEMBER 31, ENDED -------------------------------------------------- SEPTEMBER 30, 2000 1999 1998 1997 1996 2001 -------- -------- ------- ------- -------- ------------- (AMOUNTS IN THOUSANDS OF DOLLARS) Loss from continuing operations before loss from equity investee............ $(17,077) $(18,911) $(6,141) $(8,176) $(18,174) $(46,746) ======== ======== ======= ======= ======== ======== Fixed charges: Interest expense............. $ 281 $ 284 $ 428 $ 735 $ 940 $ 130 Interest portion of rent expense.................... 1,028 994 887 1,057 1,136 890 -------- -------- ------- ------- -------- -------- Total fixed charges.......... $ 1,309 $ 1,278 $ 1,315 $ 1,792 $ 2,076 $ 1,020 ======== ======== ======= ======= ======== ======== Loss from continuing operations before loss from equity investee plus fixed charges.................... $(15,768) $(17,633) $(4,826) $(6,384) $(16,098) $(45,726) ======== ======== ======= ======= ======== ======== Ratio of earnings to fixed charges(A)................. -- -- -- -- -- --
--------------- (A) Due to the registrant's losses for the years ended December 31, 2000, 1999, 1998, 1997 and 1996 and for the nine months ended September 30, 2001, the ratio coverage was less than 1:1. The registrant must generate additional earnings of $17,077, $18,911, $6,141, $8,176, $18,174 and $46,746 for the years ended December 31, 2000, 1999, 1998, 1997 and 1996 and for the nine months ended September 30, 2001, respectively, to achieve a coverage ratio of 1:1.